Prostate MR imaging at high-field strength: evolution or revolution?

As 3 T MR scanners become more available, body imaging at high field strength is becoming the subject of intensive research. However, little has been published on prostate imaging at 3 T. Will high-field imaging dramatically increase our ability to depict and stage prostate cancer? This paper will address this question by reviewing the advantages and drawbacks of body imaging at 3 T and the current limitations of prostate imaging at 1.5 T, and by detailing the preliminary results of prostate 3 T MRI. Even if slight adjustments of imaging protocols are necessary for taking into account the changes in T1 and T2 relaxation times at 3 T, tissue contrast in T2-weighted (T2w) imaging seems similar at 1.5 T and 3 T. Therefore, significant improvement in cancer depiction in T2w imaging is not expected. However, increased spatial resolution due to increased signal-to-noise ratio (SNR) may improve the detection of minimal capsular invasion. Higher field strength should provide increased spectral and spatial resolution for spectroscopic imaging, but new pulse sequences will have to be designed for overcoming field inhomogeneities and citrate J-modulation issues. Finally, dynamic contrast-enhanced MRI is the method of imaging that is the most likely to benefit from the increased SNR, with a significantly better trade-off between temporal and spatial resolution.

[1]  T. D. de Reijke,et al.  Current Status of Minimally Invasive Treatment Options for Localized Prostate Carcinoma , 2000, European Urology.

[2]  Dennis W J Klomp,et al.  Optimal timing for in vivo 1H‐MR spectroscopic imaging of the human prostate at 3T , 2005, Magnetic resonance in medicine.

[3]  Arend Heerschap,et al.  Fast acquisition‐weighted three‐dimensional proton MR spectroscopic imaging of the human prostate , 2004, Magnetic resonance in medicine.

[4]  W S Ng,et al.  Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. , 2004, The Journal of urology.

[5]  B. Nicolas Bloch,et al.  3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1). , 2004, Academic radiology.

[6]  G P Liney,et al.  In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland , 1999, NMR in biomedicine.

[7]  T Okada,et al.  Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. , 2001, Urology.

[8]  G P Liney,et al.  Differentiation of prostatic carcinoma and benign prostatic hyperplasia: Correlation between dynamic Gd‐DTPA‐enhanced MR imaging and histopathology , 1999, Journal of magnetic resonance imaging : JMRI.

[9]  3.0-T high-field magnetic resonance imaging of the female pelvis: preliminary experiences , 2005, European Radiology.

[10]  K. Taari,et al.  Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual-echo, steady-state sequences , 2001, European Radiology.

[11]  S. F. Quinn,et al.  MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens. , 1994, Radiology.

[12]  H M Pollack,et al.  Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. , 1993, The Journal of urology.

[13]  H. Huisman,et al.  Accurate estimation of pharmacokinetic contrast‐enhanced dynamic MRI parameters of the prostate , 2001, Journal of magnetic resonance imaging : JMRI.

[14]  R. Oyen Dynamic contrast-enhanced MRI of the prostate: Is this the way to proceed for characterization of prostatic carcinoma? , 2003, European Radiology.

[15]  H. Schlemmer,et al.  Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? , 2004, European Radiology.

[16]  G. Parker,et al.  Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience. , 2004, Radiology.

[17]  J R Thornbury,et al.  Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. , 1997, Radiology.

[18]  Jacob Sosna,et al.  MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. , 2004, Academic radiology.

[19]  P. Walsh,et al.  Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. , 2002, The Journal of urology.

[20]  P. Boesiger,et al.  Optimizing PRESS localized citrate detection at 3 Tesla , 2005, Magnetic resonance in medicine.

[21]  M. L. Lauzon,et al.  Magnetic Resonance Imaging at 3.0 Tesla: Challenges and Advantages in Clinical Neurological Imaging , 2003, Investigative radiology.

[22]  Hiroto Hatabu,et al.  MR imaging at high magnetic fields. , 2003, European journal of radiology.

[23]  J Kurhanewicz,et al.  The prostate: MR imaging and spectroscopy. Present and future. , 2000 .

[24]  A Heerschap,et al.  Fast dynamic gadolinium‐enhanced MR imaging of urinary bladder and prostate cancer , 1999, Journal of magnetic resonance imaging : JMRI.

[25]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[26]  Dennis W J Klomp,et al.  Initial Experience of 3 Tesla Endorectal Coil Magnetic Resonance Imaging and 1H-Spectroscopic Imaging of the Prostate , 2004, Investigative radiology.

[27]  J. Severens,et al.  Patient Selection for Magnetic Resonance Imaging of Prostate Cancer , 2001, European Urology.

[28]  Anwar R. Padhani,et al.  Dynamic Contrast-Enhanced MRI of Prostate Cancer , 2005 .

[29]  A. Shmuel,et al.  Imaging brain function in humans at 7 Tesla , 2001, Magnetic resonance in medicine.

[30]  R. Balaban,et al.  Musculoskeletal MR imaging at 4 T and at 1.5 T: comparison of relaxation times and image contrast. , 1995, Radiology.

[31]  Fritz Schick,et al.  Whole-body MRI at high field: technical limits and clinical potential , 2005, European Radiology.

[32]  M. van der Graaf,et al.  Human prostate: multisection proton MR spectroscopic imaging with a single spin-echo sequence--preliminary experience. , 1999, Radiology.

[33]  X Golay,et al.  Comparison of the dependence of blood R2 and R  2* on oxygen saturation at 1.5 and 4.7 Tesla , 2003, Magnetic resonance in medicine.

[34]  B. Daniel,et al.  In vivo prostate magnetic resonance spectroscopic imaging using two‐dimensional J‐resolved PRESS at 3 T , 2005, Magnetic resonance in medicine.

[35]  M. Zelefsky Three-dimensional conformal brachytherapy for prostate cancer , 2004, Current urology reports.

[36]  J R Thornbury,et al.  Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. , 1996, AJR. American journal of roentgenology.

[37]  C P Langlotz,et al.  Prostate cancer: what is the future role for imaging? , 2001, AJR. American journal of roentgenology.

[38]  Lawrence L Wald,et al.  Comparison of Cardiac MRI on 1.5 and 3.0 Tesla Clinical Whole Body Systems , 2003, Investigative radiology.

[39]  P. Barker,et al.  Single‐voxel proton MRS of the human brain at 1.5T and 3.0T , 2001, Magnetic resonance in medicine.

[40]  M. van der Graaf,et al.  Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin‐echo pulse sequence , 1997, Magnetic resonance in medicine.

[41]  H. Thaler,et al.  Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? , 1996, The Journal of urology.

[42]  J Kurhanewicz,et al.  Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. , 1998, Radiology.

[43]  D. Mitchell,et al.  Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. , 1994, Radiology.

[44]  Hee-Won Kim,et al.  In Vivo Prostate Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy at 3 Tesla Using a Transceive Pelvic Phased Array Coil: Preliminary Results , 2003, Investigative radiology.

[45]  C W Piccoli,et al.  Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. , 1994, Radiology.

[46]  L. Dougherty,et al.  High field body MR imaging: preliminary experiences. , 2004, Clinical imaging.

[47]  S. Kitano,et al.  Diagnostic usefulness of endorectal magnetic resonance imaging with dynamic contrast‐enhancement in patients with localized prostate cancer: Mapping studies with biopsy specimens , 1999, International journal of urology : official journal of the Japanese Urological Association.

[48]  Jelle O. Barentsz,et al.  Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis , 2002, European Radiology.

[49]  J R Thornbury,et al.  Prostate cancer staging: should MR imaging be used?--A decision analytic approach. , 2000, Radiology.

[50]  Henkjan J Huisman,et al.  Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.

[51]  J. Kurhanewicz,et al.  Magnetic Resonance Imaging and Spectroscopic Imaging of Prostate Cancer , 2001, Cancer investigation.

[52]  J Kurhanewicz,et al.  Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 1999, Radiology.

[53]  Local Staging of Prostatic Carcinoma: Comparison of Transrectal Sonography and Endorectal MR Imaging , 1996 .

[54]  R. Menon,et al.  Comparison of the quantification precision of human short echo time 1H spectroscopy at 1.5 and 4.0 Tesla , 2000, Magnetic resonance in medicine.

[55]  Michael W Kattan,et al.  Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. , 2004, Radiology.

[56]  Olivier Rouvière,et al.  Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging , 2003, European Radiology.

[57]  N. Rofsky,et al.  MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. , 2004, Radiology.

[58]  J. Chapelon,et al.  Transrectal High Intensity Focused Ultrasound for the Treatment of Localized Prostate Cancer: Factors Influencing the Outcome , 2001, European Urology.

[59]  R S Balaban,et al.  MR relaxation times in human brain: measurement at 4 T. , 1996, Radiology.

[60]  S. Majumdar,et al.  Cartilage MR imaging at 3.0 versus that at 1.5 T: preliminary results in a porcine model. , 2005, Radiology.

[61]  Mark Rijpkema,et al.  Combined quantitative dynamic contrast‐enhanced MR imaging and 1H MR spectroscopic imaging of human prostate cancer , 2004, Journal of magnetic resonance imaging : JMRI.

[62]  A. Prando Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. , 2002, International braz j urol : official journal of the Brazilian Society of Urology.

[63]  Kevin F King,et al.  Cardiac magnetic resonance parallel imaging at 3.0 Tesla: Technical feasibility and advantages , 2004, Journal of magnetic resonance imaging : JMRI.

[64]  R Alagappan,et al.  Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. , 1997, Radiology.

[65]  K. Badani,et al.  Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. , 2000, The Journal of urology.

[66]  P. Pasqualetti,et al.  Enhancement patterns of prostate cancer in dynamic MRI , 2003, European Radiology.

[67]  Olivier Rouvière,et al.  Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings. , 2004, Urology.

[68]  A. Schned,et al.  Staging of prostate cancer with endorectal MR imaging: lessons from a learning curve. , 1995, Radiographics : a review publication of the Radiological Society of North America, Inc.

[69]  D. Gillatt,et al.  A comparison of endorectal magnetic resonance imaging and transrectal ultrasonography in the local staging of prostate cancer with histopathological correlation. , 1997, British journal of urology.

[70]  P. Walsh Adult Urology: Urological Survey: Urologic Oncology: Prostate CancerProstate Cancer Localization With Endorectal MR Imaging and MR Spectroscopic Imaging: Effect of Clinical Data on Reader Accuracy , 2005 .

[71]  Juan M. Santos,et al.  Real‐time cardiac MRI at 3 tesla , 2004, Magnetic resonance in medicine.

[72]  S. Blackband,et al.  Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: Zonal and age‐related differences , 1996, Magnetic resonance in medicine.

[73]  T. Scheenen,et al.  Local staging of prostate cancer by T2-weighted imaging with an endorectal coil at 3T , 2005 .

[74]  Wolfhard Semmler,et al.  Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI , 2004, European Radiology.

[75]  Jacob Sosna,et al.  Determinations of prostate volume at 3-Tesla using an external phased array coil: comparison to pathologic specimens. , 2003, Academic radiology.

[76]  Michael Garwood,et al.  Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T , 2005, Magnetic resonance in medicine.

[77]  C. Langlotz,et al.  Prostate imaging may not be necessary in nonpalpable carcinoma of the prostate. , 1997, Urology.